Literature DB >> 26907617

Primary Cardiac Osteosarcoma.

Ji-Gang Wang1, Bing Liu2, Han Gao3, Yu-Jun Li4, Peng Zhao4, Xiu-Ping Liu5.   

Abstract

BACKGROUND: Primary cardiac osteosarcoma is extremely rare. There is no cohort study on such tumours to date. The aim of this study is to investigate the clinical characteristics and outcome patterns of such tumours.
METHODS: A thorough literature review was performed, and all relevant clinical items were collected. A total of 53 cases of primary cardiac osteosarcoma were enrolled in this study, including 25 males and 28 females.
RESULTS: The age at diagnosis ranged from 14 to 77 years with a mean age of 43.6 years. The clinical manifestations, imaging features, and laboratory tests of the primary cardiac osteosarcomas were similar to other types of primary cardiac tumours. Sex, tumour size and adjunctive chemo-radiotherapy were found to affect the overall survival pattern.
CONCLUSIONS: The present study may provide an effective consultation for the diagnosis and treatment of this tumour.
Copyright © 2016 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiac tumour; Osteosarcoma; Prognosis

Mesh:

Year:  2016        PMID: 26907617     DOI: 10.1016/j.hlc.2016.01.006

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  2 in total

1.  Primary chondroblastic osteosarcoma of the mitral valve without metastasis.

Authors:  Muhammad Umair; Stefan L Zimmerman; Elliot K Fishman
Journal:  Radiol Case Rep       Date:  2022-02-03

Review 2.  Genetic aberrations and molecular biology of cardiac sarcoma.

Authors:  Milena Urbini; Annalisa Astolfi; Valentina Indio; Margherita Nannini; Carmine Pizzi; Pasquale Paolisso; Giuseppe Tarantino; Maria Abbondanza Pantaleo; Maristella Saponara
Journal:  Ther Adv Med Oncol       Date:  2020-05-18       Impact factor: 8.168

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.